Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02246153
Other study ID # NFEC-2014-067
Secondary ID
Status Recruiting
Phase Phase 3
First received September 15, 2014
Last updated January 7, 2017
Start date September 2014
Est. completion date December 2017

Study information

Verified date January 2017
Source Nanfang Hospital of Southern Medical University
Contact Guoxin Li, M.D., Ph.D.
Phone +86-138-0277-1450
Email gzliguoxin@163.com
Is FDA regulated No
Health authority China: Ministry of Health
Study type Interventional

Clinical Trial Summary

- Laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer (EGC) has been supported by high-quality evidence, and the high-level evidence for advanced gastric cancer based on large prospective randomized controlled trial as CLASS-01、JCOG 0901, KLASS -02 is still awaited.Hopefully, it would have also gained the solid evidence of laparoscopy-assisted distal gastrectomy for the treatment of advanced gastric cancer (AGC).

- China has entered the aging society since 1999. Among the GC patients in China, the average age is 65 years old, which makes increasing attempts to explore laparoscopic techniques in the treatment of elderly patients.

- Nowadays, a considerable proportion of elderly patients suffer from multiple diseases, such as hypertension, diabetes, coronary heart disease. Thus the risk of intraoperative and postoperative complications can not be ignored. Unfortunately, there are rare studies specializing into the LAG for the GC patients of > 65 years old.

- Accordingly, the comparison of intraoperative and postoperative complications between laparoscopy-assisted and open distal gastrectomy for over 65 years old patients with gastric cancer based on a randomized controlled trial is warranted.


Recruitment information / eligibility

Status Recruiting
Enrollment 202
Est. completion date December 2017
Est. primary completion date August 2017
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria:

- Age over 65 years

- Primary gastric adenocarcinoma (papillary, tubular, mucinous, signet ring cell, or poorly differentiated) confirmed pathologically by endoscopic biopsy

- cT1-4a, N0-3, M0 at preoperative evaluation according to the AJCC Cancer Staging Manual Seventh Edition

- Expected curative resection through distal subtotal gastrectomy with D2 lymphadenectomy

- Performance status of 0 or 1 on ECOG (Eastern Cooperative Oncology Group) scale

- ASA (American Society of Anesthesiology) score class I, II, or III

- Written informed consent

Exclusion Criteria:

- Severe mental disorder

- History of previous upper abdominal surgery (except laparoscopic cholecystectomy)

- History of previous gastrectomy, endoscopic mucosal resection or endoscopic submucosal dissection

- Exclude the early gastric cancer feasible for ESD

- Enlarged or bulky regional lymph node diameter over 3cm by preoperative imaging

- History of other malignant disease within past five years

- History of previous neoadjuvant chemotherapy or radiotherapy

- History of unstable angina or myocardial infarction within past six months

- History of cerebrovascular accident within past six months

- History of continuous systematic administration of corticosteroids within one month

- Requirement of simultaneous surgery for other disease

- Emergency surgery due to complication (bleeding, obstruction or perforation) caused by gastric cancer

- FEV1<50% of predicted values

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Laparoscopic gastrectomy
After exclusion of T4b, bulky lymph nodes, or distant metastasis case by diagnostic laparoscopy, laparoscopic distal subtotal gastrectomy and D2 lymph node dissection will be performed with curative treated intent. The type of reconstruction will be selected according to the surgeon's experience and anastomotic procedure is performed extracorporeally using a mini-laparotomy.
Open gastrectomy
After exclusion of T4b, bulky lymph nodes, or distant metastasis case by diagnostic laparoscopy, open distal subtotal gastrectomy and D2 lymph node dissection will be performed with curative treated intent. The type of reconstruction will be selected according to the surgeon's experience.

Locations

Country Name City State
China Nanfang Hospital, Southern Medical University Guangzhou

Sponsors (1)

Lead Sponsor Collaborator
Nanfang Hospital of Southern Medical University

Country where clinical trial is conducted

China, 

References & Publications (1)

Yu J, Hu J, Huang C, Ying M, Peng X, Wei H, Jiang Z, Du X, Liu Z, Liu H, Li G; Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group.. The impact of age and comorbidity on postoperative complications in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: results from the Chinese laparoscropic gastrointestinal surgery study (CLASS) group. Eur J Surg Oncol. 2013 Oct;39(10):1144-9. doi: 10.1016/j.ejso.2013.06.021. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative complication rate 30 day morbidity and mortality 30 days Yes
Secondary Postoperative pulmonary complications Pulmonary complications after operation within 30 days 30 days Yes
Secondary Postoperative recovery index participants will be followed for the duration of hospital stay after operation, an expected average of 7 days 7 days No
See also
  Status Clinical Trial Phase
Recruiting NCT02228473 - Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort N/A
Recruiting NCT01917253 - Standard Length Catheters vs Long Catheters in Peripheral Vein Cannulation. N/A
Completed NCT02245854 - Efficacy and Safety of a New Polypectomy Snare for Cold-polypectomy for Small Colorectal Polyps N/A
Completed NCT01574196 - Assessment of Cardiac Autonomic Function in Adulthood After Chemotherapy or Radiotherapy in Childhood N/A
Completed NCT02447523 - The Impact of Metabolic Syndrome on Patients Undergoing Elective Laparotomy N/A
Terminated NCT00616824 - The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction Phase 4
Completed NCT04061655 - Effect of Intravenous Iron Supplementation in Reducing Allogenic Blood Transfusion Early Phase 1
Recruiting NCT03984747 - Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection
Completed NCT03641365 - Sleeves Versus Sleeveless Template N/A
Completed NCT02901665 - Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes N/A
Completed NCT02675166 - Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes
Completed NCT01997658 - Preoperative Glucocorticoid Use in Major Hepatectomy Phase 2/Phase 3
Not yet recruiting NCT02252445 - Propofol and Sevoflurane for Catheter-Related Bladder Discomfort N/A
Active, not recruiting NCT01775150 - Saving Mother and Baby With Text Messaging N/A
Completed NCT01631799 - Outcome of Patients After Total Knee Replacement: A Comparison of Femoral Nerve Block and Epidural Anesthesia N/A
Completed NCT03440138 - Defining Benchmarks in Bariatric Surgery
Recruiting NCT02835404 - Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer Phase 2
Completed NCT01489800 - The Impact of Early Feeding After Radical Cystectomy for Bladder Cancer N/A
Completed NCT02096224 - Sevoflurane Versus Desflurane for Catheter-related Bladder Discomfort N/A
Completed NCT01531478 - Long-term Follow-up of Childhood Cancer Survivors in the Rhône-Alpes and Auvergne Regions of France N/A